Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity

F. Šenigl, AI. Soikkeli, S. Prost, DG. Schatz, M. Slavková, J. Hejnar, J. Alinikula

. 2024 ; 18 (-) : 200293. [pub] 20241028

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003178

Simian virus 40 (SV40) is a monkey virus with tumorigenic potential in rodents and is associated with several types of human cancers, including lymphomas. A related Merkel cell polyomavirus causes carcinoma in humans by expressing truncated large tumor antigen (LT), with truncations caused by APOBEC family of cytidine deaminase-induced mutations. AID (activation-induced cytidine deaminase), a member of the APOBEC family, is the initiator of the antibody diversification process known as somatic hypermutation and its aberrant expression and targeting is a frequent source of lymphomagenesis. In this study, we investigated whether AID could cause mutations in SV40 LT. We demonstrate that the SV40 enhancer has strong somatic hypermutation targeting activity in several cell types and that AID-induced mutations accumulate in SV40 LT in B cells and kidney cells and cause truncated LT expression in B cells. Our results argue that the ability of the SV40 enhancer to target somatic hypermutation to LT is a potential source of LT truncation events that could contribute to tumorigenesis in various cell types, thereby linking SV40 infection with malignant development through a novel mutagenic pathway.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003178
003      
CZ-PrNML
005      
20250411093647.0
007      
ta
008      
250121e20241028ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.tvr.2024.200293 $2 doi
035    __
$a (PubMed)39490533
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Šenigl, Filip $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic. Electronic address: filip.senigl@img.cas.cz
245    14
$a The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity / $c F. Šenigl, AI. Soikkeli, S. Prost, DG. Schatz, M. Slavková, J. Hejnar, J. Alinikula
520    9_
$a Simian virus 40 (SV40) is a monkey virus with tumorigenic potential in rodents and is associated with several types of human cancers, including lymphomas. A related Merkel cell polyomavirus causes carcinoma in humans by expressing truncated large tumor antigen (LT), with truncations caused by APOBEC family of cytidine deaminase-induced mutations. AID (activation-induced cytidine deaminase), a member of the APOBEC family, is the initiator of the antibody diversification process known as somatic hypermutation and its aberrant expression and targeting is a frequent source of lymphomagenesis. In this study, we investigated whether AID could cause mutations in SV40 LT. We demonstrate that the SV40 enhancer has strong somatic hypermutation targeting activity in several cell types and that AID-induced mutations accumulate in SV40 LT in B cells and kidney cells and cause truncated LT expression in B cells. Our results argue that the ability of the SV40 enhancer to target somatic hypermutation to LT is a potential source of LT truncation events that could contribute to tumorigenesis in various cell types, thereby linking SV40 infection with malignant development through a novel mutagenic pathway.
650    12
$a opičí virus SV40 $x genetika $7 D013539
650    _2
$a lidé $7 D006801
650    12
$a zesilovače transkripce $x genetika $7 D004742
650    _2
$a zvířata $7 D000818
650    12
$a cytidindeaminasa $x genetika $x metabolismus $7 D003564
650    _2
$a B-lymfocyty $x virologie $x metabolismus $x imunologie $7 D001402
650    _2
$a somatická hypermutace imunoglobulinových genů $x genetika $7 D027041
650    _2
$a mutace $7 D009154
650    _2
$a antigeny virové nádorové $x genetika $x metabolismus $7 D000957
650    _2
$a karcinogeneze $x genetika $7 D063646
650    _2
$a buněčné linie $7 D002460
650    _2
$a infekce onkogenními viry $x genetika $x virologie $7 D014412
650    _2
$a polyomavirové infekce $x genetika $x virologie $7 D027601
650    _2
$a antigeny transformující polyomavirové $x genetika $x metabolismus $7 D000952
650    _7
$a AICDA (aktivací indukovaná cytidindeamináza) $2 czmesh $7 D000098830
655    _2
$a časopisecké články $7 D016428
700    1_
$a Soikkeli, Anni I $u Institute of Biomedicine, University of Turku, Turku, 20520, Finland; Turku Doctoral Programme of Molecular Medicine, University of Turku, Turku, Finland
700    1_
$a Prost, Salomé $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
700    1_
$a Schatz, David G $u Department of Immunobiology, Yale School of Medicine, New Haven.CT, 06520-8011, USA
700    1_
$a Slavková, Martina $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
700    1_
$a Hejnar, Jiří $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, 14220, Czech Republic
700    1_
$a Alinikula, Jukka $u Institute of Biomedicine, University of Turku, Turku, 20520, Finland. Electronic address: jukka.alinikula@utu.fi
773    0_
$w MED00216054 $t Tumour virus research $x 2666-6790 $g Roč. 18 (20241028), s. 200293
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39490533 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250411093639 $b ABA008
999    __
$a ok $b bmc $g 2263120 $s 1239185
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 18 $c - $d 200293 $e 20241028 $i 2666-6790 $m Tumour virus research $n Tumour Virus Res $x MED00216054
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...